TECH logo

Bio-Techne Corporation (TECH) Cash From Financing

Annual CFF:

-$253.91M-$131.51M(-107.44%)
June 30, 2025

Summary

  • As of today, TECH annual cash from financing is -$253.91 million, with the most recent change of -$131.51 million (-107.44%) on June 30, 2025.
  • During the last 3 years, TECH annual cash from financing has fallen by -$11.05 million (-4.55%).
  • TECH annual cash from financing is now -234.26% below its all-time high of $189.11 million, reached on June 30, 2017.

Performance

TECH Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTECHcash flow metrics

Quarterly CFF:

-$44.20M+$46.25M(+51.13%)
September 30, 2025

Summary

  • As of today, TECH quarterly cash from financing is -$44.20 million, with the most recent change of +$46.25 million (+51.13%) on September 30, 2025.
  • Over the past year, TECH quarterly cash from financing has dropped by -$32.63 million (-282.02%).
  • TECH quarterly cash from financing is now -118.25% below its all-time high of $242.16 million, reached on September 30, 2016.

Performance

TECH Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTECHcash flow metrics

TTM CFF:

-$286.54M-$32.63M(-12.85%)
September 30, 2025

Summary

  • As of today, TECH TTM cash from financing is -$286.54 million, with the most recent change of -$32.63 million (-12.85%) on September 30, 2025.
  • Over the past year, TECH TTM cash from financing has dropped by -$81.06 million (-39.45%).
  • TECH TTM cash from financing is now -251.52% below its all-time high of $189.11 million, reached on June 30, 2017.

Performance

TECH TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTECHcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TECH Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-107.4%-282.0%-39.5%
3Y3 Years-4.5%-39.0%-21.9%
5Y5 Years-38.1%-26.5%-47.4%

TECH Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-1222.7%at low-129.3%+51.1%-327.5%at low
5Y5-Year-1222.7%at low-129.3%+51.1%-327.5%at low
All-TimeAll-Time-234.3%at low-118.3%+57.4%-251.5%at low

TECH Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$44.20M(+51.1%)
-$286.54M(-12.9%)
Jun 2025
-$253.91M(-107.4%)
-$90.45M(-32.9%)
-$253.91M(-13.6%)
Mar 2025
-
-$68.05M(+18.8%)
-$223.55M(-7.5%)
Dec 2024
-
-$83.84M(-624.5%)
-$207.92M(-1.2%)
Sep 2024
-
-$11.57M(+80.7%)
-$205.48M(-67.9%)
Jun 2024
-$122.40M(-641.2%)
-$60.09M(-14.7%)
-$122.40M(-41.5%)
Mar 2024
-
-$52.42M(+35.6%)
-$86.53M(-174.1%)
Dec 2023
-
-$81.40M(-213.8%)
$116.73M(-7.3%)
Sep 2023
-
$71.51M(+395.2%)
$125.93M(+456.8%)
Jun 2023
$22.62M(+109.3%)
-$24.22M(-116.1%)
$22.62M(+219.7%)
Mar 2023
-
$150.84M(+308.9%)
-$18.89M(+92.6%)
Dec 2022
-
-$72.19M(-127.0%)
-$253.79M(-8.0%)
Sep 2022
-
-$31.81M(+51.6%)
-$234.97M(+3.2%)
Jun 2022
-$242.85M(-288.2%)
-$65.73M(+21.8%)
-$242.85M(-308.6%)
Mar 2022
-
-$84.06M(-57.5%)
-$59.44M(-94.2%)
Dec 2021
-
-$53.38M(-34.5%)
-$30.60M(+54.5%)
Sep 2021
-
-$39.68M(-133.7%)
-$67.30M(-7.6%)
Jun 2021
-$62.55M(+66.0%)
$117.69M(+313.1%)
-$62.55M(+72.2%)
Mar 2021
-
-$55.23M(+38.7%)
-$224.96M(-20.0%)
Dec 2020
-
-$90.08M(-157.9%)
-$187.52M(+3.6%)
Sep 2020
-
-$34.93M(+21.9%)
-$194.47M(-5.8%)
Jun 2020
-$183.80M(-236.8%)
-$44.72M(-151.4%)
-$183.80M(-15.6%)
Mar 2020
-
-$17.79M(+81.7%)
-$158.98M(+5.5%)
Dec 2019
-
-$97.03M(-299.8%)
-$168.24M(-49.7%)
Sep 2019
-
-$24.27M(-22.0%)
-$112.42M(-183.7%)
Jun 2019
$134.38M(+235.5%)
-$19.90M(+26.4%)
$134.38M(+46.9%)
Mar 2019
-
-$27.04M(+34.4%)
$91.45M(-22.2%)
Dec 2018
-
-$41.21M(-118.5%)
$117.54M(-32.6%)
Sep 2018
-
$222.53M(+454.2%)
$174.30M(+275.7%)
Jun 2018
-$99.19M(-152.4%)
-$62.83M(-6500.0%)
-$99.19M(-87.1%)
Mar 2018
-
-$952.00K(-106.1%)
-$53.00M(+30.8%)
Dec 2017
-
$15.55M(+130.5%)
-$76.57M(+26.4%)
Sep 2017
-
-$50.95M(-206.1%)
-$104.00M(-155.0%)
Jun 2017
$189.11M(+919.3%)
-$16.64M(+32.1%)
$189.11M(+8.9%)
Mar 2017
-
-$24.52M(-106.3%)
$173.71M(-2.8%)
Dec 2016
-
-$11.88M(-104.9%)
$178.70M(+0.8%)
Sep 2016
-
$242.16M(+855.6%)
$177.22M(+867.7%)
Jun 2016
-$23.08M(-173.8%)
-$32.05M(-64.0%)
-$23.08M(+69.9%)
Mar 2016
-
-$19.54M(-46.2%)
-$76.71M(-12.5%)
Dec 2015
-
-$13.37M(-131.9%)
-$68.18M(-132.5%)
Sep 2015
-
$41.87M(+148.9%)
-$29.33M(-193.8%)
Jun 2015
$31.28M(+185.0%)
-$85.68M(-678.9%)
$31.28M(-71.3%)
Mar 2015
-
-$11.00M(-143.2%)
$108.94M(-1.0%)
Dec 2014
-
$25.48M(-75.1%)
$110.03M(+45.6%)
Sep 2014
-
$102.47M(+1379.4%)
$75.57M(+305.3%)
Jun 2014
-$36.81M(+17.6%)
-$8.01M(+19.2%)
-$36.81M(+11.1%)
Mar 2014
-
-$9.91M(-10.3%)
-$41.38M(+2.7%)
Dec 2013
-
-$8.98M(+9.3%)
-$42.52M(+3.0%)
Sep 2013
-
-$9.90M(+21.3%)
-$43.83M(+1.9%)
Jun 2013
-$44.68M(+30.9%)
-$12.58M(-13.9%)
-$44.68M(-0.3%)
Mar 2013
-
-$11.05M(-7.3%)
-$44.54M(+4.6%)
Dec 2012
-
-$10.30M(+4.2%)
-$46.69M(+13.3%)
Sep 2012
-
-$10.75M(+13.6%)
-$53.82M(+16.7%)
Jun 2012
-$64.63M(-78.1%)
-$12.45M(+5.7%)
-$64.63M(-7.0%)
Mar 2012
-
-$13.20M(+24.3%)
-$60.42M(-5.6%)
Dec 2011
-
-$17.43M(+19.2%)
-$57.24M(-22.0%)
Sep 2011
-
-$21.56M(-161.6%)
-$46.93M(-29.3%)
Jun 2011
-$36.29M(+28.2%)
-$8.24M(+17.7%)
-$36.29M(+29.0%)
Mar 2011
-
-$10.02M(-40.7%)
-$51.08M(-2.9%)
Dec 2010
-
-$7.12M(+34.8%)
-$49.63M(+3.7%)
Sep 2010
-
-$10.91M(+52.6%)
-$51.54M(-2.0%)
Jun 2010
-$50.51M(+57.7%)
-$23.03M(-168.8%)
-$50.51M(-30.6%)
Mar 2010
-
-$8.57M(+5.2%)
-$38.68M(+22.3%)
Dec 2009
-
-$9.03M(+8.6%)
-$49.79M(+56.9%)
Sep 2009
-
-$9.89M(+11.7%)
-$115.61M(+3.2%)
Jun 2009
-$119.44M(-111.1%)
-$11.20M(+43.1%)
-$119.44M(-0.7%)
Mar 2009
-
-$19.67M(+73.7%)
-$118.58M(+6.7%)
Dec 2008
-
-$74.85M(-445.6%)
-$127.05M(-77.8%)
Sep 2008
-
-$13.72M(-32.8%)
-$71.46M(-26.3%)
Jun 2008
-$56.59M
-$10.33M(+63.3%)
-$56.59M(-25.9%)
Mar 2008
-
-$28.15M(-46.1%)
-$44.96M(-190.4%)
Dec 2007
-
-$19.27M(-1771.2%)
-$15.48M(-74.4%)
DateAnnualQuarterlyTTM
Sep 2007
-
$1.15M(-11.7%)
-$8.88M(+22.0%)
Jun 2007
-$11.38M(-43.6%)
$1.31M(-1.8%)
-$11.38M(+16.6%)
Mar 2007
-
$1.33M(+110.5%)
-$13.64M(-310.3%)
Dec 2006
-
-$12.67M(-842.5%)
-$3.32M(+79.5%)
Sep 2006
-
-$1.34M(-40.4%)
-$16.18M(-104.2%)
Jun 2006
-$7.92M(+91.8%)
-$957.00K(-108.2%)
-$7.92M(-289.3%)
Mar 2006
-
$11.64M(+145.6%)
-$2.04M(+98.3%)
Dec 2005
-
-$25.52M(-469.4%)
-$117.39M(-29.7%)
Sep 2005
-
$6.91M(+40.1%)
-$90.47M(+6.9%)
Jun 2005
-$97.16M(-3498.5%)
$4.93M(+104.8%)
-$97.16M(+4.1%)
Mar 2005
-
-$103.71M(-7539.5%)
-$101.33M(-2749.8%)
Dec 2004
-
$1.39M(+536.5%)
$3.82M(+60.9%)
Sep 2004
-
$219.00K(-71.4%)
$2.38M(-16.9%)
Jun 2004
$2.86M(+113.6%)
$766.00K(-47.0%)
$2.86M(+324.0%)
Mar 2004
-
$1.45M(+2826.4%)
$674.30K(+104.3%)
Dec 2003
-
-$53.00K(-107.6%)
-$15.57M(-8.7%)
Sep 2003
-
$701.00K(+149.4%)
-$14.32M(+31.9%)
Jun 2003
-$21.03M(-1520.3%)
-$1.42M(+90.4%)
-$21.03M(-4.7%)
Mar 2003
-
-$14.80M(-1336.6%)
-$20.10M(-275.3%)
Dec 2002
-
$1.20M(+119.9%)
-$5.35M(+19.2%)
Sep 2002
-
-$6.01M(-1148.4%)
-$6.63M(-410.7%)
Jun 2002
-$1.30M(-10.7%)
-$481.80K(-782.4%)
-$1.30M(-33.9%)
Mar 2002
-
-$54.60K(+31.2%)
-$969.40K(+48.0%)
Dec 2001
-
-$79.40K(+88.4%)
-$1.87M(+11.9%)
Sep 2001
-
-$682.40K(-346.0%)
-$2.12M(-80.4%)
Jun 2001
-$1.17M(-104.5%)
-$153.00K(+83.9%)
-$1.17M(-176.9%)
Mar 2001
-
-$950.40K(-187.0%)
$1.53M(-71.1%)
Dec 2000
-
-$331.10K(-226.7%)
$5.28M(-11.0%)
Sep 2000
-
$261.30K(-89.7%)
$5.93M(-77.4%)
Jun 2000
$26.23M(+1035.0%)
$2.55M(-9.3%)
$26.23M(+19.4%)
Mar 2000
-
$2.81M(+780.0%)
$21.96M(+13.2%)
Dec 1999
-
$318.90K(-98.4%)
$19.40M(+4.5%)
Sep 1999
-
$20.56M(+1295.8%)
$18.55M(+761.3%)
Jun 1999
-$2.81M(-538.5%)
-$1.72M(-826.1%)
-$2.81M(-242.2%)
Mar 1999
-
$236.80K(+145.1%)
-$819.70K(-6.3%)
Dec 1998
-
-$524.70K(+34.3%)
-$770.80K(-762.2%)
Sep 1998
-
-$798.10K(-399.7%)
$116.40K(-81.8%)
Jun 1998
$639.80K(+124.2%)
$266.30K(-6.8%)
$639.80K(+8.0%)
Mar 1998
-
$285.70K(-21.2%)
$592.50K(+183.6%)
Dec 1997
-
$362.50K(+232.0%)
-$708.90K(+48.9%)
Sep 1997
-
-$274.70K(-225.4%)
-$1.39M(+47.5%)
Jun 1997
-$2.64M(-2367.2%)
$219.00K(+121.6%)
-$2.64M(+0.5%)
Mar 1997
-
-$1.02M(-220.3%)
-$2.66M(-75.6%)
Dec 1996
-
-$317.10K(+79.3%)
-$1.51M(-6.5%)
Sep 1996
-
-$1.53M(-845.6%)
-$1.42M(-1226.3%)
Jun 1996
-$107.10K(+76.1%)
$205.00K(+60.2%)
-$107.10K(+88.2%)
Mar 1996
-
$128.00K(+156.9%)
-$910.00K(+12.3%)
Dec 1995
-
-$225.00K(-4.6%)
-$1.04M(-45.6%)
Sep 1995
-
-$215.10K(+64.0%)
-$713.00K(-43.2%)
Jun 1995
-$448.70K(-6131.9%)
-$597.90K(>-9900.0%)
-$497.90K(-597.9%)
Mar 1995
-
$0.00(-100.0%)
$100.00K(0.0%)
Dec 1994
-
$100.00K(>+9900.0%)
$100.00K(>+9900.0%)
Sep 1994
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1994
-$7200.00(-107.1%)
$0.00(0.0%)
$0.00(0.0%)
Mar 1994
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1993
-
$0.00(0.0%)
$0.00(-100.0%)
Sep 1993
-
$0.00(0.0%)
$100.00K(0.0%)
Jun 1993
$102.10K(+126.2%)
$0.00(0.0%)
$100.00K(+150.0%)
Mar 1993
-
$0.00(-100.0%)
-$200.00K(+33.3%)
Dec 1992
-
$100.00K(>+9900.0%)
-$300.00K(0.0%)
Sep 1992
-
$0.00(+100.0%)
-$300.00K(+25.0%)
Jun 1992
-$389.70K(-94.8%)
-$300.00K(-200.0%)
-$400.00K(0.0%)
Mar 1992
-
-$100.00K(-200.0%)
-$400.00K(-100.0%)
Dec 1991
-
$100.00K(+200.0%)
-$200.00K(+33.3%)
Sep 1991
-
-$100.00K(+66.7%)
-$300.00K(-50.0%)
Jun 1991
-$200.00K(+50.0%)
-$300.00K(-400.0%)
-$200.00K(0.0%)
Mar 1991
-
$100.00K(>+9900.0%)
-$200.00K(+60.0%)
Dec 1990
-
$0.00(0.0%)
-$500.00K(0.0%)
Sep 1990
-
$0.00(+100.0%)
-$500.00K(-25.0%)
Jun 1990
-$400.00K
-$300.00K(-50.0%)
-$400.00K(-300.0%)
Mar 1990
-
-$200.00K(>-9900.0%)
-$100.00K(-200.0%)
Dec 1989
-
$0.00(-100.0%)
$100.00K(0.0%)
Sep 1989
-
$100.00K
$100.00K

FAQ

  • What is Bio-Techne Corporation annual cash from financing?
  • What is the all-time high annual cash from financing for Bio-Techne Corporation?
  • What is Bio-Techne Corporation annual cash from financing year-on-year change?
  • What is Bio-Techne Corporation quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Bio-Techne Corporation?
  • What is Bio-Techne Corporation quarterly cash from financing year-on-year change?
  • What is Bio-Techne Corporation TTM cash from financing?
  • What is the all-time high TTM cash from financing for Bio-Techne Corporation?
  • What is Bio-Techne Corporation TTM cash from financing year-on-year change?

What is Bio-Techne Corporation annual cash from financing?

The current annual cash from financing of TECH is -$253.91M

What is the all-time high annual cash from financing for Bio-Techne Corporation?

Bio-Techne Corporation all-time high annual cash from financing is $189.11M

What is Bio-Techne Corporation annual cash from financing year-on-year change?

Over the past year, TECH annual cash from financing has changed by -$131.51M (-107.44%)

What is Bio-Techne Corporation quarterly cash from financing?

The current quarterly cash from financing of TECH is -$44.20M

What is the all-time high quarterly cash from financing for Bio-Techne Corporation?

Bio-Techne Corporation all-time high quarterly cash from financing is $242.16M

What is Bio-Techne Corporation quarterly cash from financing year-on-year change?

Over the past year, TECH quarterly cash from financing has changed by -$32.63M (-282.02%)

What is Bio-Techne Corporation TTM cash from financing?

The current TTM cash from financing of TECH is -$286.54M

What is the all-time high TTM cash from financing for Bio-Techne Corporation?

Bio-Techne Corporation all-time high TTM cash from financing is $189.11M

What is Bio-Techne Corporation TTM cash from financing year-on-year change?

Over the past year, TECH TTM cash from financing has changed by -$81.06M (-39.45%)
On this page